Shukra Pharmaceuticals has received authorized distributor certificate from Integra Medical Devices India. As per this authorization, the company empowered to promote, market, and supply the medical equipment and devices of Integra Medical Devices India for all Directorate General Armed Forces Medical Services (DGAFMS) affiliated projects across Defence Hospitals, Commands, and related Defence Organisations Pan-India.
It further operates as the official distributor for all DGAFMS-related procurement activities initiated from the date of issuance of the authorization letter; and collaborate closely with Integra Lifesciences on all projects, including adherence to mutually agreed commercial terms, compliance norms, and ethical business standards. The authorization is valid till December 31, 2026, unless terminated earlier as per the terms of the letter.
Shukra Pharmaceuticals is an ambitious organisation with a deep-rooted focus on sustainability with its impressive range of solutions.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: